Jazz Pharmaceuticals
JAZZ
#1528
Rank
C$19.59 B
Marketcap
C$301.79
Share price
3.92%
Change (1 day)
58.37%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2026 (TTM): C$1.01 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are C$4.60 Billion. In 2025 the company made an earning of -C$0.88 Billion a decrease over its 2024 earnings that were of C$0.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$1.01 B-215.55%
2025 -C$0.88 Billion-233.49%
2024 C$0.65 B57.87%
2023 C$0.41 B-179.92%
2022 -C$0.53 Billion230.37%
2021 -C$0.16 Billion-141.02%
2020 C$0.38 B-39.45%
2019 C$0.63 B-14.2%
2018 C$0.73 B20.03%
2017 C$0.61 B-17.15%
2016 C$0.74 B22.14%
2015 C$0.60 B187.64%
2014 C$0.21 B-50.79%
2013 C$0.43 B73.63%
2012 C$0.24 B41.69%
2011 C$0.17 B116.61%
2010 C$80.74 M262.77%
2009 C$22.25 M-111.33%
2008 -C$0.2 Billion1.31%
2007 -C$0.2 Billion77.8%
2006 -C$0.11 Billion36.59%
2005 -C$79.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$21.68 B 2,033.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
C$2.92 B 188.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-C$3.35 Billion-428.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
C$2.24 B 120.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel